Close Menu

NEW YORK ─  Sienna Cancer Diagnostics said on Tuesday that it has made Triolab the exclusive distributor of its hTERT bladder cancer test in Sweden.

Sienna's in vitro diagnostic test detects the hTERT component of telomerase, a biomarker that aids in the diagnosis of bladder cancer alongside standard urine cytology testing. Under the distribution agreement, Triolab will sell Sienna’s hTERT biomarker test to Swedish pathology laboratories. Melbourne, Australia-based Sienna said that Unilabs, a commercial lab in Sweden, is evaluating the hTERT test for routine use.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.